Equity · Healthcare
JNJ
NYSEJohnson & Johnson (JNJ)
The line runs 254 USD on 3 August through 273.18 USD on 30 October, on a scale from 240 to 280. Days the market did not trade hold the previous close, flat.
- Market cap
- 657.6B USD
- P/E (TTM)
- 41.5
- Revenue, year to Dec 2025
- 94.2B USD
- EPS, diluted, year to Dec 2025
- 11.03 USD
- 52-week range
- 186 USD – 278.28 USD
- Avg volume
- 308.6K
- Mentions, 30 days
- 86
- Net sentiment
- +0.06
as of Oct 30, 2026
Have Johnson & Johnson (JNJ) insiders bought or sold shares recently?
In the 90 days to 31 Oct 2026, Johnson & Johnson insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 13 Feb 2026, show no open-market purchase.
Form 4, 90 days to 31 Oct 2026, newest reported trade 2 Sep 2026
Buys 0Sells 5Net sold $61.99MOther filings 4
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Sep 2026 | Schmid TimothyEVP, WW Chair, MedTech | Sell | 33,597 | 9.2M USD |
| 17 Aug 2026 | Taubert Jennifer LEVP, WWC. Innovative Medicine | Sell | 15,000 | 4.0M USD |
| 13 Aug 2026 | Duato JoaquinCEO and Chairman of the Board | Sell | 123,291 | 32.2M USD |
| 06 Aug 2026 | Forminard ElizabethEVP, Chief Legal Officer | Sell | 15,918 | 4.1M USD |
| 05 Aug 2026 | Duato JoaquinCEO and Chairman of the Board | Sell | 48,480 | 12.5M USD |
| Sold | 5 open-market sales | 236,286 | $61.99M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Sep 2026 | Schmid TimothyEVP, WW Chair, MedTech | Option exercise | 33,597 | 4.9M USD |
| 17 Aug 2026 | Taubert Jennifer LEVP, WWC. Innovative Medicine | Option exercise | 15,000 | 1.7M USD |
| 13 Aug 2026 | Duato JoaquinCEO and Chairman of the Board | Option exercise | 123,291 | 14.3M USD |
| 06 Aug 2026 | Forminard ElizabethEVP, Chief Legal Officer | Option exercise | 9,344 | 1.2M USD |
Which funds hold Johnson & Johnson (JNJ)?
12 of the 45 institutional funds we track reported a Johnson & Johnson position for the quarter ended 30 Jun 2026 — a combined 6.1B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Added | 13,307,056 | 3.4B USD | +43.6% |
| Marshall Wace | Added | 2,989,537 | 759.3M USD | +25.7% |
| AQR Capital Management | Held (±25%) | 2,907,803 | 738.5M USD | −17.9% |
| Citadel Advisors | Held (±25%) | 1,500,832 | 381.2M USD | −22.3% |
| D. E. Shaw & Co. | Held (±25%) | 687,227 | 174.5M USD | −10.1% |
| Bridgewater Associates | Held (±25%) | 669,135 | 169.9M USD | −4.0% |
| Millennium Management | Held (±25%) | 594,091 | 150.9M USD | +3.2% |
| Balyasny Asset Management | Held (±25%) | 584,500 | 148.4M USD | −2.7% |
| Man Group | Added | 517,830 | 131.5M USD | +62.8% |
| GAMCO Investors | Held (±25%) | 80,050 | 20.3M USD | −0.5% |
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Have members of Congress traded Johnson & Johnson (JNJ)?
The most recent congressional trade disclosed in Johnson & Johnson is a purchase by Lloyd Doggett (house, TX), dated 08 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 08 Sep 2026 | Lloyd Doggetthouse · Democrat–TX | Purchase | 1K USD–15K USD | 27 days |
| 29 Jun 2026 | Thomas H. Kean, Jr.house · Republican–NJ | Sale | 1K USD–15K USD | 16 days |
| 26 Mar 2026 | Thomas H. Kean, Jr.house · Republican–NJ | Sale | 1K USD–15K USD | 18 days |
| 19 Mar 2026 | Richard McCormickhouse · Republican–GA | Sale | 1K USD–15K USD | 19 days |
| 09 Dec 2025 | Lloyd Doggetthouse · Democrat–TX | Purchase | 1K USD–15K USD | 24 days |
| 13 Nov 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 05 Nov 2025 | Richard McCormickhouse · Republican–GA | Purchase | 1K USD–15K USD | 34 days |
| 31 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 21 days |
What has been filed or recorded for Johnson & Johnson (JNJ)?
The filings we hold for Johnson & Johnson, newest first: 14 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 157 shares | 39K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 766 shares | 196K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 9 shares | 2K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 372 shares | 94K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,175 shares | 557K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 129 shares | 35K USD notional · <0.001% of shares out |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,453 shares | 1.2M USD notional · <0.001% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 196 shares | 53K USD notional · <0.001% of shares out |
| 27 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.09 USD | |
| 27 Sep 2026 | Financials | Total assets | 197.4B USD | at period end |
| 27 Sep 2026 | Financials | Total equity | 81.5B USD | at period end |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 889 shares | 241K USD notional · <0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 7,954 shares | 2.1M USD notional · <0.001% of shares out |
| 23 Sep 2026 | Fails to deliver | Shares failed to deliver | 6,029 shares | 1.6M USD notional · <0.001% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 99 shares | 27K USD notional · <0.001% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 89,357 shares | 24.1M USD notional · 0.004% of shares out |
| 17 Sep 2026 | Fails to deliver | Shares failed to deliver | 61 shares | 16K USD notional · <0.001% of shares out |
| 28 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.27 USD | |
| 29 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 2.14 USD | |
| 28 Dec 2025 | Annual report | FY 2025 reported | EPS 11.03 USD | |
| 28 Dec 2025 | Financials | Revenue | 94.2B USD | fiscal year |
| 28 Dec 2025 | Financials | Net income | 26.8B USD | fiscal year |
| 28 Dec 2025 | Financials | Diluted EPS | 11.03 USD | fiscal year |
| 28 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 2.12 USD | |
| 29 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 2.29 USD | |
| 30 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 4.54 USD | |
| 29 Dec 2024 | Annual report | FY 2024 reported | EPS 5.79 USD |
What is Reddit saying about Johnson & Johnson (JNJ)?
Reddit mentioned JNJ 86 times in the 30 days to 31 October 2026, across 6 of the communities we track. All of them were scored for sentiment: 52% read bullish, 15% bearish and 33% neither. Reddit data updated 31 October 2026.
30-day window, Method
Mentions, 30 days 86Bullish 52%Bearish 15%Communities 6Against the market −2 points
How do Reddit mentions of Johnson & Johnson (JNJ) compare with its price?
Share ↗
Is the Reddit crowd more bullish on Johnson & Johnson than on the market?
JNJ reads 60% bullish, 7 points above the market (53%). Over 90 days the gap has run from -27 to +26 points.
- JNJ
- 60%
- bullish, 31 Oct
- Market
- 53%
- bullish, all Reddit, 31 Oct
- Gap
- +7 pts
- JNJ against market
Where Johnson & Johnson (JNJ) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 77% | 66 | +0.04 |
| r/investing | 8% | 7 | +0.07 |
| r/stocks | 8% | 7 | +0.16 |
| r/etfs | 3% | 3 | +0.14 |
| r/ausfinance | 2% | 2 | +0.03 |
| r/options | 1% | 1 | +0.12 |
Moves with Johnson & Johnson (JNJ)
Tickers whose daily Reddit volume rose and fell with Johnson & Johnson (JNJ)'s. Co-discussion, not price.
AVNV +0.61DFAX +0.58TIN +0.56BUFF +0.54BX +0.53IJH +0.53
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Johnson & Johnson (JNJ): frequently asked questions
What did Johnson & Johnson shares close at?
Johnson & Johnson closed at 273.18 USD on 30 Oct 2026, down 1.11% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Johnson & Johnson’s market cap?
Johnson & Johnson is worth 657.6B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Johnson & Johnson’s P/E ratio?
Johnson & Johnson has a price-to-earnings ratio of 41.5, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Johnson & Johnson’s revenue?
Johnson & Johnson reported revenue of 94.2B USD for the year ended 28 Dec 2025, as filed with the SEC. See Filings
Have Johnson & Johnson insiders bought or sold shares recently?
In the 90 days to 31 Oct 2026, Johnson & Johnson insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 13 Feb 2026, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Johnson & Johnson?
12 of the 45 funds we track reported a Johnson & Johnson position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, Marshall Wace and AQR Capital Management. See Funds
Have members of Congress traded Johnson & Johnson?
Yes. 107 trades in Johnson & Johnson appear in the congressional disclosures we hold; the latest is a purchase by Lloyd Doggett (House, TX) dated 8 Sep 2026, filed 5 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Johnson & Johnson last report earnings?
Johnson & Johnson last reported earnings on 27 Sep 2026 for Q3 2026, with EPS of 0.09 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Johnson & Johnson?
Johnson & Johnson was mentioned 20 times in the last 7 days across the finance subreddits we track, and 86 times over the trailing 30 days. Of the 86 mentions scored for sentiment, 52% read bullish and 15% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 27 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings